Terms: = Prostate cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
102 results:
1. Synthesis, molecular docking and biological evaluation of 1,2,4-oxadiazole based novel non-steroidal derivatives against prostate cancer.
Kumar S; Wadhwa P
Bioorg Chem; 2024 Feb; 143():107029. PubMed ID: 38091717
[TBL] [Abstract] [Full Text] [Related]
2. Can systemic immune-inflammation index and hematologic parameters aid in decision-making for active surveillance or curative treatment in low-risk prostate cancer?
Baylan B; Ulusoy K; Ekenci B; Kartal IG
Asian J Surg; 2024 Mar; 47(3):1360-1365. PubMed ID: 38065745
[TBL] [Abstract] [Full Text] [Related]
3. LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients.
Boehle A; Zywietz D; Robrahn-Nitschke I; Lusch A; König IR
Urol Oncol; 2023 Nov; 41(11):454.e17-454.e24. PubMed ID: 37714724
[TBL] [Abstract] [Full Text] [Related]
4. Targeted Therapy for cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.
Choi HY; Chang JE
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686423
[TBL] [Abstract] [Full Text] [Related]
5. Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells.
Wang Z; Li Y; Zhao W; Jiang S; Huang Y; Hou J; Zhang X; Zhai Z; Yang C; Wang J; Zhu J; Pan J; Jiang W; Li Z; Ye M; Tan M; Jiang H; Dang Y
Signal Transduct Target Ther; 2023 May; 8(1):175. PubMed ID: 37121942
[TBL] [Abstract] [Full Text] [Related]
6. The 17-Gene Genomic prostate Score Test Is Prognostic for Outcomes After Primary External Beam Radiation Therapy in Men With Clinically Localized prostate cancer.
Janes JL; Boyer MJ; Bennett JP; Thomas VM; De Hoedt AM; Edwards V DK; Singla PK; Abran JM; Aboushwareb T; Salama JK; Freedland SJ
Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):120-131. PubMed ID: 36306979
[TBL] [Abstract] [Full Text] [Related]
7. Radiotherapy activity in the COVID 19 pandemic: Brazil's operational national-level study.
Moraes FY; Gouveia AG; Lima RP; Bratti VF; Hamamura AC; Viani GA
J Cancer Policy; 2023 Jun; 36():100367. PubMed ID: 36216270
[TBL] [Abstract] [Full Text] [Related]
8. Impact of different unconditional monetary incentives on survey response rates in men with prostate cancer: a 2-arm randomised trial.
McIntosh M; Opozda MJ; O'Callaghan M; Vincent AD; Galvão DA; Short CE
BMC Med Res Methodol; 2022 Sep; 22(1):252. PubMed ID: 36175831
[TBL] [Abstract] [Full Text] [Related]
9. Radiation and Chemotherapy are Associated with Altered Aortic Aneurysm Growth in Patients with cancer: Impact of Synchronous cancer and Aortic Aneurysm.
Becker von Rose A; Kobus K; Bohmann B; Lindquist-Lilljequist M; Eilenberg W; Bassermann F; Reeps C; Eckstein HH; Trenner M; Maegdefessel L; Neumayer C; Brostjan C; Roy J; Hultgren R; Schwaiger BJ; Busch A
Eur J Vasc Endovasc Surg; 2022; 64(2-3):255-264. PubMed ID: 35853577
[TBL] [Abstract] [Full Text] [Related]
10. Real-World Cabazitaxel Use and Outcomes in Metastatic Castrate-Resistant prostate cancer: The Impact of Response to First ARPI.
Watson AS; Gagnon R; Batuyong E; Alimohamed N; Lee-Ying R
Clin Genitourin Cancer; 2022 Oct; 20(5):496.e1-496.e9. PubMed ID: 35599196
[TBL] [Abstract] [Full Text] [Related]
11. First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the prostate cancer Registry.
Galli L; Chiuri VE; Di Lorenzo G; Pisconti S; Rossetti S; Sirotova Z; Muto A; Petrioli R; De Tursi M; Sbrana A; Francolini G; Ardizzoia A; Scavelli C; Satta F; Quadrini S; Airoldi M; D'Aniello C; Bonetti A; Conforti S; Aieta M; Beccaglia P; Maestri A; Fratino L
Tumori; 2023 Apr; 109(2):224-232. PubMed ID: 35400269
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological and genetic analyses of small cell neuroendocrine carcinoma of the prostate: Histological features for accurate diagnosis and toward future novel therapies.
Ida A; Okubo Y; Kasajima R; Washimi K; Sato S; Yoshioka E; Osaka K; Suzuki T; Yamamoto Y; Yokose T; Kishida T; Miyagi Y
Pathol Res Pract; 2022 Jan; 229():153731. PubMed ID: 34952423
[TBL] [Abstract] [Full Text] [Related]
13. prostate-specific antigen density during dutasteride treatment for 1 year predicts the presence of prostate cancer in benign prostatic hyperplasia after the first negative biopsy (PREDICT study).
Inoue T; Yoshimura K; Terada N; Tsukino H; Murota T; Kinoshita H; Kamoto T; Ogawa O; Matsuda T
Int J Urol; 2021 Aug; 28(8):849-854. PubMed ID: 34008275
[TBL] [Abstract] [Full Text] [Related]
14. Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment.
Wong SK; Hamm J; Shokoohi A; McGahan CE; Ho C
BMC Cancer; 2021 Mar; 21(1):215. PubMed ID: 33653306
[TBL] [Abstract] [Full Text] [Related]
15. Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the treatment of Low- and Intermediate-Risk prostate cancer.
Gogineni E; Rana Z; Soberman D; Sidiqi B; D'Andrea V; Lee L; Potters L; Parashar B
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1232-1242. PubMed ID: 33171199
[TBL] [Abstract] [Full Text] [Related]
16. Anesthesia concerns in prostate brachytherapy: An institutional experience.
Kumar V; Ahuja D; Gupta N; Bharati SJ; Garg R; Mishra S; Haresh KP; Gupta S; Bhatnagar S
Indian J Cancer; 2020; 57(4):411-415. PubMed ID: 33078747
[TBL] [Abstract] [Full Text] [Related]
17. Targetable gene fusions and aberrations in genitourinary oncology.
Pederzoli F; Bandini M; Marandino L; Ali SM; Madison R; Chung J; Ross JS; Necchi A
Nat Rev Urol; 2020 Nov; 17(11):613-625. PubMed ID: 33046892
[TBL] [Abstract] [Full Text] [Related]
18. Temporal Trends and Practice Patterns for Inpatient Management of Malignant Extrinsic Ureteral Obstruction in the United States.
Haas CR; Shah O; Hyams ES
J Endourol; 2020 Aug; 34(8):828-835. PubMed ID: 32340482
[No Abstract] [Full Text] [Related]
19. [Palmitoylome profiling indicates that androgens promote the palmitoylation of metabolism-related proteins in prostate cancer-derived LNCaP cells].
Li WQ; Ren SM; Long XB; Tian YQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Apr; 52(2):227-233. PubMed ID: 32306003
[TBL] [Abstract] [Full Text] [Related]
20. Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with
Ettala O; Malaspina S; Tuokkola T; Luoto P; Löyttyniemi E; Boström PJ; Kemppainen J
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):665-673. PubMed ID: 31879814
[TBL] [Abstract] [Full Text] [Related]
[Next]
